ALGS · Forms 3, 4, 5
Insider trades at Aligos Therapeutics, Inc.
No open-market insider buys or sells at Aligos Therapeutics, Inc. in the last 90 days; 10 filings reported awards, option exercises, tax withholding or new insiders.
Every Form 3, 4 and 5 filed for Aligos Therapeutics, Inc. (ALGS) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Most recent insider filings
No Form 3, 4 or 5 filings for Aligos Therapeutics, Inc. in the last 90 days. The latest ones on EDGAR:
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Heather Preston | Director | Options or other derivatives | Form 4 | ||||
| Margarita Chavez | Director | Options or other derivatives | Form 4 | ||||
| Bridget A Martell | Director | Options or other derivatives | Form 4 | ||||
| James Paul Scopa | Director | Options or other derivatives | Form 4 | ||||
| Carole Nuechterlein | Director | Options or other derivatives | Form 4 | ||||
| Peter Hirth | Director | Options or other derivatives | Form 4 | ||||
| Julian A. Symons | Officer | Options or other derivatives | Form 4 | ||||
| Nikhil Aneja | Principal Accounting Officer | Options or other derivatives | Form 4 | ||||
| Lesley Ann Calhoun | Officer | Options or other derivatives | Form 4 | ||||
| Lawrence Blatt | President and CEO | Options or other derivatives | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.